Skip to main content

LATEST NEWS

Recent Articles from TheStreet

Low Inflation Rate Confounds Economists, Though Maybe the Internet Explains It

Inflation Is Here. How Prepared Is Your Portfolio? FREE Webinar

Investors worried about inflation should take these steps to protect their portfolios. Top experts from Action Alerts PLUS, VanEck, and Quadratic Capital join TheStreet's free webinar: 'How to Play the Inflation Trade.

Exxon Mobil

Exxon CEO Woods Rejects Biden's Move Against Oil Companies

President Biden has pointed to oil companies as a possible scapegoat for our inflation, Exxon's CEO Darren Woods wants none of it.

How to Trade KB Home and Lennar Stock Ahead of Earnings Reports

Lennar Stock Climbs on Goldman Sachs Upgrade to Buy

Lennar's roll out of larger, volume focused communities should support double digit revenue growth, Goldman Sachs says.

Disney Lead

Disney Stock: Is 'Hawkeye's' Slow Start a Red Flag?

The Disney+ streaming service’s latest Marvel show gets a soft reception.

Workers are seen at the installation site of reactor pressure vessel of the No.5 unit of China National Nuclear Corporation's Fuqing nuclear power plant in southeast Fujian Province, in January 2018. Photo: Xinhua

Commonwealth Fusion, Backed by Gates, Soros, Benioff, Raises $1.8B

Commonwealth Fusion's investors include Google, Bill Gates and funds controlled by George Soros and Marc Benioff.

iPhone Apple Lead

Are You Long Apple as Stock Makes All-Time Highs Again?

Apple stock continues to bombard its way to new all-time highs. Here's how to trade it now that it's doing so again.

Capital One Reports Data Breach Hitting 100 Million Customers

Capital One Ends its Overdraft, Non-Sufficient Fund Fees

Overdraft fees can be $25-$35 a pop. The step will cost Capital One $150 million in revenue annually, the company said.

Build-A-Bear Lead

5 Top Stock Gainers for Wednesday: Dow Rebounds From Hawkish Powell, Omicron Variant Fears

Box, Build-A-Bear-Workshop, Ambarella, Lennar and Arbutus Biopharma are five top stock gainers for Wednesday.

Bristol-Myers Gears Up for Earnings as Activist Investor Looms

Bristol Myers Represents Attractive Opportunity, BofA Says

Looking to 2022, BofA said it is modeling about $3 billion in new product sales, up 155% year-on-year, for Bristol Myers.

Toys 'R' Us CEO on the Holidays, Doing Battle With Amazon

Toys R Us To Attempt Another Mall Comeback With New Flagship Store

Toys R Us is planning a comeback with the launch of a new flagship store in New Jersey.